Ductal Carcinoma In Situ (DCIS) Diagnosed by MRI-Guided Biopsy among <i>BRCA1/BRCA2</i> Mutation Carriers

<div>40 year-old BRCA1 patient undergoing annual MRI. Axial (a) and Sagittal (b) reconstruction showing a segmental nonmass enhancement in the left breast (red arrow). Mediolateral (MLO) view of mammography of the same breast shows no corresponding calcifications.</div>

The Breast Journal

fig2

Figure 2

Figure 2: Ductal Carcinoma In Situ (DCIS) Diagnosed by MRI-Guided Biopsy among <i>BRCA1/BRCA2</i> Mutation Carriers 

The Breast Journal

Ductal Carcinoma In Situ (DCIS) Diagnosed by MRI-Guided Biopsy among BRCA1/BRCA2 Mutation Carriers

Figure 2